Total Payments
$9,039
2024 Payments
$1,278
Companies
58
Transactions
475
Medicare Patients
596
Medicare Billing
$65,823
Payment Breakdown by Category
Food & Beverage$8,912 (98.6%)
Other$126.14 (1.4%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $8,912 | 468 | 98.6% |
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $126.14 | 7 | 1.4% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Biogen, Inc. | $686.35 | 34 | $0 (2024) |
| UCB, Inc. | $572.19 | 33 | $0 (2024) |
| EMD Serono, Inc. | $572.04 | 32 | $0 (2024) |
| Novartis Pharmaceuticals Corporation | $545.32 | 30 | $0 (2024) |
| GENZYME CORPORATION | $489.63 | 25 | $0 (2024) |
| JAZZ PHARMACEUTICALS INC. | $448.33 | 18 | $0 (2024) |
| Lilly USA, LLC | $423.97 | 25 | $0 (2024) |
| Alexion Pharmaceuticals, Inc. | $387.94 | 15 | $0 (2024) |
| Genentech USA, Inc. | $356.47 | 17 | $0 (2024) |
| ACADIA Pharmaceuticals Inc | $328.63 | 18 | $0 (2023) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $1,278 | 62 | UCB, Inc. ($129.55) |
| 2023 | $2,901 | 143 | Biogen, Inc. ($333.52) |
| 2022 | $2,054 | 106 | EMD Serono, Inc. ($191.97) |
| 2021 | $1,103 | 57 | EMD Serono, Inc. ($106.80) |
| 2019 | $624.48 | 38 | ACADIA Pharmaceuticals Inc ($78.35) |
| 2018 | $893.98 | 57 | Mallinckrodt LLC ($151.88) |
| 2017 | $184.03 | 12 | AstraZeneca Pharmaceuticals LP ($45.41) |
All Payment Transactions
475 individual payment records from CMS Open Payments — Page 1 of 19
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 11/20/2024 | PFIZER INC. | NURTEC ODT (Drug), ZAVZPRET | Food and Beverage | In-kind items and services | $24.42 | General |
| Category: PAIN | ||||||
| 11/14/2024 | SUN PHARMACEUTICAL INDUSTRIES INC. | — | Food and Beverage | In-kind items and services | $50.11 | General |
| 08/08/2024 | SUN PHARMACEUTICAL INDUSTRIES INC. | — | Food and Beverage | In-kind items and services | $17.37 | General |
| 07/13/2024 | Biogen, Inc. | AVONEX (Biological), TYSABRI, VUMERITY | Food and Beverage | In-kind items and services | $18.87 | General |
| Category: Neurology | ||||||
| 06/21/2024 | Novartis Pharmaceuticals Corporation | KESIMPTA (Drug) | Food and Beverage | In-kind items and services | $22.67 | General |
| Category: Neurology | ||||||
| 06/14/2024 | Celgene Corporation | ZEPOSIA (Drug) | Food and Beverage | Cash or cash equivalent | $20.20 | General |
| Category: Neuroscience | ||||||
| 06/13/2024 | ABBVIE INC. | QULIPTA (Drug), UBRELVY | Food and Beverage | In-kind items and services | $19.91 | General |
| Category: NEUROSCIENCE | ||||||
| 06/12/2024 | CATALYST PHARMACEUTICALS, INC. | FIRDAPSE (Drug) | Food and Beverage | Cash or cash equivalent | $15.45 | General |
| Category: NEUROLOGY | ||||||
| 06/10/2024 | UCB, Inc. | Briviact (Drug) | Food and Beverage | In-kind items and services | $18.61 | General |
| Category: Neurology | ||||||
| 05/24/2024 | Novartis Pharmaceuticals Corporation | KESIMPTA (Drug) | Food and Beverage | In-kind items and services | $19.87 | General |
| Category: Neurology | ||||||
| 05/17/2024 | CSL Behring | Hizentra (Biological) | Food and Beverage | In-kind items and services | $16.71 | General |
| Category: Immunology | ||||||
| 05/13/2024 | PFIZER INC. | NURTEC ODT (Drug), ZAVZPRET | Food and Beverage | In-kind items and services | $14.93 | General |
| Category: PAIN | ||||||
| 05/06/2024 | ARGENX US, INC. | VYVGART HYTRULO (Drug) | Food and Beverage | In-kind items and services | $18.83 | General |
| Category: Neurology | ||||||
| 05/02/2024 | UCB, Inc. | Briviact (Drug) | Food and Beverage | In-kind items and services | $29.23 | General |
| Category: Neurology | ||||||
| 05/02/2024 | JAZZ PHARMACEUTICALS INC. | XYWAV (Drug) | Food and Beverage | In-kind items and services | $18.40 | General |
| Category: NEUROLOGY | ||||||
| 04/30/2024 | Kedrion Biopharma, Inc. | Albuked (Biological), KOATE, GAMMAKED | Food and Beverage | Cash or cash equivalent | $21.03 | General |
| Category: Critical Care | ||||||
| 04/26/2024 | Genentech USA, Inc. | Ocrevus (Biological) | Food and Beverage | In-kind items and services | $20.00 | General |
| Category: Immunology | ||||||
| 04/23/2024 | SK Life Science, Inc. | — | Food and Beverage | In-kind items and services | $17.27 | General |
| 04/23/2024 | Lilly USA, LLC | AMYVID (Drug) | Food and Beverage | In-kind items and services | $14.44 | General |
| Category: Neuroscience | ||||||
| 04/19/2024 | Novartis Pharmaceuticals Corporation | KESIMPTA (Drug) | Food and Beverage | In-kind items and services | $20.95 | General |
| Category: Neurology | ||||||
| 04/18/2024 | Alnylam Pharmaceuticals Inc. | AMVUTTRA (Drug) | Food and Beverage | In-kind items and services | $20.76 | General |
| Category: Genetic Disease | ||||||
| 04/17/2024 | Teva Pharmaceuticals USA, Inc. | Austedo XR (Drug) | Food and Beverage | In-kind items and services | $30.03 | General |
| Category: Central Nervous System | ||||||
| 04/16/2024 | CSL Behring | Hizentra (Biological) | Food and Beverage | In-kind items and services | $20.77 | General |
| Category: Immunology | ||||||
| 04/15/2024 | UCB, Inc. | Rystiggo (Drug) | Food and Beverage | In-kind items and services | $19.34 | General |
| Category: Neurology | ||||||
| 04/11/2024 | Biogen, Inc. | TYSABRI (Biological), VUMERITY | Food and Beverage | In-kind items and services | $18.98 | General |
| Category: Neurology | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 5 | 151 | 186 | $49,440 | $16,474 |
| 2022 | 5 | 222 | 249 | $66,615 | $24,229 |
| 2021 | 5 | 196 | 227 | $59,768 | $22,857 |
| 2020 | 2 | 27 | 31 | $6,917 | $2,263 |
Total Patients
596
Total Services
693
Medicare Billing
$65,823
Procedure Codes
17
All Medicare Procedures & Services
17 procedure records from CMS Medicare Utilization
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99223 | Initial hospital care with moderate level of medical decision making, if using time, at least 75 minutes | Facility | 2023 | 72 | 79 | $30,810 | $10,211 | 33.1% |
| 99222 | Initial hospital care with straightforward or low-level medical decision making, if using time, at least 55 minutes | Facility | 2023 | 26 | 26 | $6,916 | $2,517 | 36.4% |
| 99233 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 50 minutes | Facility | 2023 | 22 | 25 | $5,000 | $2,126 | 42.5% |
| G0316 | Prolonged hospital inpatient or observation care evaluation and management service(s) beyond the total time for the primary service (when the primary service has been selected using time on the date of the primary service); each additional 15 minutes by th | Facility | 2023 | 14 | 38 | $3,762 | $864.88 | 23.0% |
| 95816 | Measurement of brain wave activity (eeg), awake and drowsy | Facility | 2023 | 17 | 18 | $2,952 | $755.82 | 25.6% |
| 99222 | Initial hospital inpatient care per day, typically 50 minutes | Facility | 2022 | 118 | 128 | $34,048 | $12,740 | 37.4% |
| 99223 | Initial hospital inpatient care per day, typically 70 minutes | Facility | 2022 | 44 | 45 | $17,550 | $6,561 | 37.4% |
| 99233 | Follow-up hospital inpatient care per day, typically 35 minutes | Facility | 2022 | 17 | 33 | $6,600 | $2,551 | 38.7% |
| 95816 | Measurement of brain wave activity (eeg), awake and drowsy | Facility | 2022 | 28 | 28 | $4,592 | $1,213 | 26.4% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Facility | 2022 | 15 | 15 | $3,825 | $1,164 | 30.4% |
| 99223 | Initial hospital inpatient care, typically 70 minutes per day | Facility | 2021 | 73 | 75 | $29,319 | $11,396 | 38.9% |
| 99222 | Initial hospital inpatient care, typically 50 minutes per day | Facility | 2021 | 45 | 45 | $12,015 | $4,594 | 38.2% |
| 99233 | Subsequent hospital inpatient care, typically 35 minutes per day | Facility | 2021 | 34 | 51 | $10,200 | $3,998 | 39.2% |
| 99232 | Subsequent hospital inpatient care, typically 25 minutes per day | Facility | 2021 | 26 | 38 | $5,282 | $2,072 | 39.2% |
| 95816 | Measurement and recording of brain wave (eeg) activity, awake and drowsy | Facility | 2021 | 18 | 18 | $2,952 | $795.96 | 27.0% |
| 99204 | New patient office or other outpatient visit, typically 45 minutes | Facility | 2020 | 12 | 12 | $3,516 | $1,182 | 33.6% |
| 99214 | Established patient office or other outpatient, visit typically 25 minutes | Facility | 2020 | 15 | 19 | $3,401 | $1,081 | 31.8% |
About Dr. Robert Jensen, MD
Dr. Robert Jensen, MD is a Ophthalmology healthcare provider based in Lexington, Kentucky. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 02/27/2007. The National Provider Identifier (NPI) number assigned to this provider is 1083741961.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Robert Jensen, MD has received a total of $9,039 in payments from pharmaceutical and medical device companies, with $1,278 received in 2024. These payments were reported across 475 transactions from 58 companies. The most common payment nature is "Food and Beverage" ($8,912).
As a Medicare-enrolled provider, Jensen has provided services to 596 Medicare beneficiaries, totaling 693 services with total Medicare billing of $65,823. Data is available for 4 years (2020–2023), covering 17 distinct procedure/service records.
Ad
Practice Information
- Specialty Ophthalmology
- Other Specialties Neuro-ophthalmology, Otology & Neurotology
- Location Lexington, KY
- Active Since 02/27/2007
- Last Updated 03/10/2025
- Taxonomy Code 207W00000X
- Entity Type Individual
- NPI Number 1083741961
Products in Payments
- KESIMPTA (Drug) $478.23
- Briviact (Drug) $448.65
- EPIDIOLEX (Drug) $361.65
- TYSABRI (Biological) $346.95
- NUPLAZID (Drug) $328.63
- ULTOMIRIS (Biological) $313.97
- AUBAGIO (Drug) $305.14
- BAFIERTAM (Drug) $254.55
- EMGALITY (Drug) $235.94
- VYEPTI (Biological) $232.90
- UBRELVY (Drug) $219.91
- ZEPOSIA (Drug) $218.48
- AVONEX (Biological) $210.62
- NURTEC ODT (Drug) $209.42
- VYVGART (Drug) $193.31
- Aimovig (Biological) $189.98
- MAVENCLAD (Drug) $188.93
- AMYVID (Drug) $188.03
- OCREVUS (Biological) $169.71
- FIRDAPSE (Drug) $169.62
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Ophthalmology Doctors in Lexington
Dr. John Kitchens, M.d, M.D
Ophthalmology — Payments: $1.2M
Ophthalmology $1.2M
Dr. Jeremy Kieval, M.d, M.D
Ophthalmology — Payments: $354,855
Ophthalmology $354,855
Gary Wortz, Md, MD
Ophthalmology — Payments: $195,872
Ophthalmology $195,872
Blake Isernhagen, Md, MD
Ophthalmology — Payments: $188,723
Ophthalmology $188,723
Dr. Bruce Koffler, Md, MD
Ophthalmology — Payments: $100,236
Ophthalmology $100,236
Kunal Kanitkar, M.d, M.D
Ophthalmology — Payments: $75,249
Ophthalmology $75,249